Exicure Inc

NASDAQ:XCUR  
1.48
-0.06 (-3.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)125.57M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.65 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$1.70
50-Day MA$2.02
200-Day MA$1.98
See more pivots

Exicure Inc Stock, NASDAQ:XCUR

2430 North Halsted Street, Suite 410, Chicago, Illinois 60614
United States of America
Phone: +1.847.673.1700
Number of Employees: 63

Description

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.